New HAP2 status meeting
Non classé
1st HAP2 paper published!
Wedata’s avatars solution certified by the French Data Protection Authority
PREV-HAP investigators’ meeting
Clinical study “PREV-HAP” submitted for approval
HAP2 leaflet now available
This leaflet contains a concise overview of the project’s concept and objectives; the presentation of two clinical trials conducted within the project; and highlights the various outputs we will offer to patients and the scientific and medical communities. See the leaflet
HAP2 kick-off meeting
All partners attended the 2-day meeting, filled with enthusiasm and collaboration as we planned the first year of the project. Over 2020, we’ll be focused on planning for our two clinical trials: PREV-HAP and TREAT-HAP, which will start in the next year in France, Spain and Greece. We’ll also be setting up the omics studies […]
